In contrast to divergent IRs with advancing age observed for ER-negative/PR-negative and ER-positive/PR-positive BC rates in the SEER population, IRs for receptor-negative BC among HL survivors approached those of receptor-positive disease as age increased (Figure 1A). The gene discussed is PGR; the disease is breast cancer.